Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review.
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
Reduction in parvalbumin-positive interneurons and inhibitory input in the cortex of mice with experimental autoimmune encephalomyelitis.
Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population.
[Phenotypes of Charcot-Marie-Tooth Syndrome and Differential Diagnosis Focused in Inflammatory Neuropathies].
Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation.
Volumetric Examination of MS Plaques and Correlation with EDSS Ratings.
Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Emerging injectable therapies for multiple sclerosis.
The immunoproteasome: a novel drug target for autoimmune diseases.
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
Examining vascular remodeling in the hypoxic central nervous system.
Functional Relapses in Pediatric Multiple Sclerosis.
Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort.
Infodemiology and infoveillance of multiple sclerosis in Italy.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.

Pages